See original story here Eight companies have been chosen to compete in this year’s BioInnovation Challenge, a regional health and life sciences business competition hosted by BioNova. The competition will go down on Nov. 7 at BioPort 2018, BioNova’s annual conference for the life-science industry at the Halifax Convention Centre. The BIC is one of the longest running business competitions in the Atlantic region. Since 2011, over 50 companies have gone through the program. Past winners of the BIC include New Brunswick-based Pfera Inc. as well as Spring Loaded Technology, ABK BioMedical and Covina Biomedical from Nova Scotia. “A strong and vibrant economy in our region requires continuous innovation and BIC has become a key program to support that,” said Scott Moffitt the Managing Director of BioNova in a statement. “Many of the companies coming out of the program have gone on to raise millions to grow and scale.” This year’s semi-finalists will receive training and sessions with expert pitching coach Linda Plano, who has over 10 years of experience mentoring entrepreneurs with startups in life sciences. The winner of the competition will also receive $25,000 in funding to develop their business idea as well as a package of support services and mentoring valued at more than $30,000. The BioPort 2018 conference is set to be the biggest yet. A Keynote address will be given by Corrina Lathan, CEO of AnthroTronix in Maryland. BioPort 2018 will also be the inaugural year for a new program for Nova Scotia’s youth. The eight BIC semi-finalists are: Coloursmith Labs – Direct-to-consumer contact lenses that work as the world’s first practical solution to colour blindness. Read Entrevestor’s coverage of Coloursmith here. Unified Health – New models designed to ease the strain on the emergency system while reducing healthcare costs and bringing better patient outcomes. The company plans to set up wellness clinics that merge traditional and alternative care practices. Talem Health Analytics – A Software-as-a-Service company for healthcare professionals to track, analyze and predict treatment regimens for people who have been in motor vehicle accidents. It draws on data from physiotherapy clinics and can help insurers assess how the patient will rehab. Talem was one of the five winners that took home $25,000 at the last Volta Cohort. Picomole – A painless, accurate, and versatile diagnostic breath test to detect early stage lung cancer. This Moncton-based company is testing its device with the Horizon Health Network in New Brunswick. Read Entrevestor’s story on Picomole here. BioHuntress – A Saint John company develping a natural treatment for blood cancer that brings a better patient experience. Neuro Amel Technologies – This Halifax-based company is building a frameless, automated brace that uses electrical stimulation to improve mobility for stroke patients. Neuro Amel recently graduated from Dalhousie University’s LaunchPad program. Read Entrevestor’s story on the early development of the project here. Macro Movements – A company that is building a software that gives feedback on your movement to prevent injury. 3F Waste Recovery – Turns waste in the fishery, farming and forestry industries into profitable solutions. The company is in the business of “turning garbage into gold,” for the cosmetics industry.]]>
BIONOVA CONTACT
#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent Posts
- MARS VR Lab
- Workinsights
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today
- NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge
Business Wire National BioTech News
- Rapid Dose Therapeutics Closes First Tranche of Private Placement
- Antibe Therapeutics Appoints New Board Chair and Corporate Vice Chairs
- Circulating Tumor Cell Market Research Report 2022 - ResearchAndMarkets.com
- First Patients Enrolled in IMPACT II Study to Evaluate Attune Medical’s ensoETM for Radiofrequency Ablation Procedures
- FSD Pharma Issues Circular, Adopts Incentive Plan and Grants PSUs
- Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting
- Miravo Healthcare™ Announces Appointment of Dale MacCandlish Weil to its Board of Directors
- Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
- Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress
- Zymeworks’ Board of Directors Unanimously Rejects Unsolicited, Non-Binding Proposal
RECENT NEWS
- MARS VR Lab January 25, 2022
- Workinsights January 25, 2022
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today November 2, 2021
- NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021
- NEWS RELEASE: BioNova supports the Government of Canada’s biomanufacturing and life sciences strategy July 30, 2021
RECENT TWEETS
Congrats to members @AdaptiivCo on their collaboration deal with printer giant HP 3D Printing and Palo Alto, California medtech specialist Varian. https://t.co/nCJfuIBZXW https://t.co/dYk1Ysyuiy
🎉Congrats to our members Precision BioLogic Inc., leading developers of #hemostasis diagnostic products, on the launch of their new product to improve testing for Hemophilia B
➡️Learn more: https://t.co/l2nsLSTgM7 https://t.co/akuFUMZhzh
➡️Learn more: https://t.co/l2nsLSTgM7 https://t.co/akuFUMZhzh
